Telmisartan
Telmisartan (CAS: 144701-48-4) is a white to off-white crystalline antihypertensive active ingredient, an angiotensin II receptor blocker used for treating essential hypertension and reducing cardiovascular risk. It is distinguished among ARBs by its long plasma half-life, which supports once-daily dosing and steady 24-hour blood-pressure control. As a bulk API it is formulated into tablets, typically alone or combined with amlodipine or hydrochlorothiazide. The compound is poorly soluble over most of the gastrointestinal pH range, so formulation scientists address bioavailability through micronization, solid dispersions, and alkalizing excipients. Customers procure it for generic and branded antihypertensive production requiring a stable, well-characterized API.
• Antihypertensive APIs: the active ingredient in telmisartan tablets for essential hypertension in adults.
• Cardiovascular protection: used for cardiovascular risk reduction in high-risk patients unable to take ACE inhibitors.
• Combination products: formulated with amlodipine and hydrochlorothiazide in single-tablet dual-therapy products.
• Formulation support: suitable for micronization and amorphous solid-dispersion techniques that enhance dissolution and bioavailability.
Product Name: Telmisartan
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.